Ken Griffin Omega Therapeutics, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 17,300 shares of OMGA stock, worth $23,701. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,300
Previous 11,000
57.27%
Holding current value
$23,701
Previous $40,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding OMGA
# of Institutions
71Shares Held
45.3MCall Options Held
36.9KPut Options Held
33.5K-
Flagship Pioneering Inc. Cambridge, MA29.2MShares$40 Million7.23% of portfolio
-
Harbourvest Partners LLC Boston, MA3.51MShares$4.81 Million3.95% of portfolio
-
State Of Wisconsin Investment Board Madison, WI1.86MShares$2.54 Million0.01% of portfolio
-
Artal Group S.A. Luxembourg, N41.32MShares$1.81 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$1.53 Million0.0% of portfolio
About Omega Therapeutics, Inc.
- Ticker OMGA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,853,400
- Market Cap $65.6M
- Description
- Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...